Congress Grills Secretive PBM Middlemen, but Misses the Most Important Point


Pharmacy benefit managers, the secretive drug middlemen that pocket billions of dollars in kickbacks, were grilled this past week at a U.S. Senate Finance Committee hearing on drug prices.

Senators asked tough questions about what exactly PBMs do – and why pharmacy benefit managers hide behind secretive contracts that withhold information from patients.

How to Lower Drug Prices


Any effective drug pricing reform must lower the drug prices that patients actually pay, independent of whether or not such reforms – given the complex nature of the prescription drug supply chain – actually lower list prices. 

Five Steps to Make Drug Pricing Reforms a Success


How can President Trump and Health and Human Services Secretary Alex Azar deliver on their new “American Patients First” plan to reduce prescription drug costs?

By focusing their evolving blueprint on the needs of patients, not lobbyists, who spend hundreds of millions of dollars each year to exert control over the many levers of health care policy. Patients are counting on reforms that don’t break what is working in an attempt to fix what’s not.

How Maine seniors can see lower drug prices


Patricia Bernard of Falmouth has unwittingly become the face of American seniors facing high drug costs.

Sen. Susan Collins recently invited Bernard to tell her story before the Senate Aging Committee, which Collins chairs. Diagnosed with rheumatoid arthritis 25 years ago, Bernard worked until age 79 to keep her employer-sponsored health insurance plan that allowed her to purchase the medication she needed for between $10 and $30 a month.